Back to results
CompletedPhase 3

Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes

NCT03344692

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University Hospital of Nantes

Nantes, France

View on ClinicalTrials.gov